Open access
9,430
Views
21
CrossRef citations to date
0
Altmetric
Review
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy
Christina ClausRoche Innovation Center Zurich, Roche Pharma Research and Early Development (pRED), Schlieren, SwitzerlandCorrespondence[email protected]
https://orcid.org/0000-0001-6316-5855View further author information
Claudia Ferrara-KollerRoche Innovation Center Zurich, Roche Pharma Research and Early Development (pRED), Schlieren, SwitzerlandView further author information
& Christian KleinRoche Innovation Center Zurich, Roche Pharma Research and Early Development (pRED), Schlieren, SwitzerlandView further author information
Article: 2167189
|
Received 21 Jul 2022, Accepted 06 Jan 2023, Published online: 01 Feb 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.